Keyphrases
12-oxo-phytodienoic Acid Reductase
22%
Acyl
11%
Acyl Chain
11%
Acylate
11%
Anti-B Cell Therapy
22%
Anti-CD20
33%
Anti-CD20 Antibody
11%
Arabidopsis Thaliana
100%
B Cells
33%
Cell Treatment
33%
Clinical Efficacy
11%
Direct Infusion
11%
Elevated Temperature
11%
Enzyme Activity
11%
Extreme Heat Stress
11%
Fatty Acyl Chains
11%
Freeze-thaw Treatment
19%
Freezing Temperature
11%
Freezing Tolerance
66%
Galactolipid
33%
Glycosylation
22%
Head Group
11%
Heat Stress
33%
Ion Leakage
30%
Leaf Lipids
33%
Lipid Levels
61%
Lipid Modification
33%
Lipid Species
11%
Lipids
66%
Lipoxygenase
15%
Lytic Therapy
11%
Mechanism of Action
11%
Membrane Lipids
11%
Monogalactosyldiacylglycerol
22%
Multiple Sclerosis
33%
Plant Freezing
11%
Plant Leaves
11%
Plant Lipids
11%
PNPLA3
15%
Primary Progressive
11%
Reductase
20%
Relapsing-remitting multiple Sclerosis
33%
Rosette
66%
Specific Lipids
22%
Sterol Esters
12%
Sterol Glucosides
22%
Sterols
22%
Sulfoquinovosyldiacylglycerol
11%
Treatment Level
11%
Ublituximab
11%
Biochemistry, Genetics and Molecular Biology
Acclimatization
11%
Acylation
8%
Arabidopsis thaliana
100%
Electrospray Ionization
5%
Enzyme
8%
Freezing Tolerance
66%
Galactolipid
25%
Glycosylation
16%
Heat Stress
33%
Lipid
100%
Lipid Composition
8%
Lipid Level
38%
Lipoxygenase
8%
Mass Spectrometry
8%
Membrane Lipid
8%
Metabolite
33%
Minoxidil
8%
Oxidoreductase
27%
Patatin-Like Phospholipase
8%
Phosphatidic Acid
8%
Phosphatidylglycerol
8%
Reductase
27%
Rosette Formation
66%
Sterol
33%
Sterol Ester
10%
Tandem Mass Spectrometry
5%
Triglyceride
8%
Wild Type
46%
Immunology and Microbiology
Acylation
11%
Arabidopsis thaliana
66%
B Cell
33%
CD20
33%
Freezing Tolerance
33%
Glycosylation
22%
Heat Stress
33%
Lipid Composition
11%
Lipid Level
27%
Metabolite
33%
Multiple Sclerosis
33%
Ocrelizumab
6%
Ofatumumab
6%
Plant Leaf
11%
Rituximab
13%
Rosette Formation
33%
Ublituximab
6%
Wild Type
44%
